pubmed.ncbi.nlm.nih.gov

Homozygous F5 deep-intronic splicing mutation resulting in severe factor V deficiency and undetectable thrombin generation in platelet-rich plasma - PubMed

️Sun Aug 23 2009

Case Reports

Homozygous F5 deep-intronic splicing mutation resulting in severe factor V deficiency and undetectable thrombin generation in platelet-rich plasma

E Castoldi et al. J Thromb Haemost. 2011 May.

Free article

Abstract

Background: Coagulation factor (F) V deficiency is associated with a bleeding tendency of variable severity, but phenotype determinants are largely unknown. Recently, we have shown that three patients with undetectable plasma FV and mild bleeding symptoms had sufficient residual platelet FV to support thrombin generation in platelet-rich plasma (PRP). Therefore, we hypothesized that FV-deficient patients with severe bleeding manifestations may lack platelet FV.

Objectives: To characterize a FV-deficient patient with a severe bleeding diathesis.

Patients/methods: We performed FV mutation screening and functional studies in a 31-year-old male (FV:C < 1%) with umbilical bleeding at birth, recurrent hemarthrosis and muscle hematomas, and a recent intracranial hemorrhage.

Results: The proband was homozygous for a deep-intronic mutation (F5 IVS8 +268A→G) causing the inclusion of a pseudo-exon with an in-frame stop codon in the mature F5 mRNA. Although platelet FV antigen was detectable by immunoprecipitation followed by Western blotting, no FV activity could be demonstrated in the proband's plasma or platelets with a prothrombinase-based assay. Moreover, no thrombin generation was observed in PRP triggered with 1-50 pm tissue factor (even in the presence of platelet agonists), whereas an acquired FV inhibitor was excluded. Clot formation in the proband's whole blood, as assessed by thromboelastometry, was markedly delayed but not abolished.

Conclusions: This is the first report of a pathogenic deep-intronic mutation in the F5 gene. Our findings indicate that the minimal FV requirement for viability is extremely low and suggest that thrombin generation in PRP may predict bleeding tendency in patients with undetectable plasma FV.

PubMed Disclaimer

Cited by

Factor V variants in bleeding and thrombosis.
Mohapatra AK, Todaro AM, Castoldi E. Mohapatra AK, et al. Res Pract Thromb Haemost. 2024 Jan 26;8(1):102330. doi: 10.1016/j.rpth.2024.102330. eCollection 2024 Jan. Res Pract Thromb Haemost. 2024. PMID: 38404937 Free PMC article.
Sensitivity and Robustness of Spatially Dependent Thrombin Generation and Fibrin Clot Propagation.
Kuprash AD, Shibeko AM, Vijay R, Nair SC, Srivastava A, Ataullakhanov FI, Panteleev MA, Balandina AN. Kuprash AD, et al. Biophys J. 2018 Dec 18;115(12):2461-2473. doi: 10.1016/j.bpj.2018.11.009. Epub 2018 Nov 14. Biophys J. 2018. PMID: 30514632 Free PMC article.
Congenital coagulation factor V deficiency with intracranial hemorrhage.
Yang J, Mao H, Sun L. Yang J, et al. J Clin Lab Anal. 2022 Nov;36(11):e24705. doi: 10.1002/jcla.24705. Epub 2022 Sep 20. J Clin Lab Anal. 2022. PMID: 36125894 Free PMC article. Review.
ST Genesia reference values of 117 healthy donors measured with STG-BleedScreen, STG-DrugScreen and STG-ThromboScreen reagents.
Ninivaggi M, de Laat-Kremers RMW, Carlo A, de Laat B. Ninivaggi M, et al. Res Pract Thromb Haemost. 2020 Dec 19;5(1):187-196. doi: 10.1002/rth2.12455. eCollection 2021 Jan. Res Pract Thromb Haemost. 2020. PMID: 33537543 Free PMC article.
Rivaroxaban Effects Illustrate the Underestimated Importance of Activated Platelets in Thrombin Generation Assessed by Calibrated Automated Thrombography.
Makhoul S, Panova-Noeva M, Regnault V, Ruf W, Wenzel P, Lagrange J. Makhoul S, et al. J Clin Med. 2019 Nov 15;8(11):1990. doi: 10.3390/jcm8111990. J Clin Med. 2019. PMID: 31731710 Free PMC article.

Homozygous F5 deep-intronic splicing mutation resulting in severe factor V deficiency and undetectable thrombin generation in platelet-rich plasma - PubMed